Does a highly sensitive thyroglobulin (Tg) assay change the clinical management of low-risk patients with thyroid cancer with Tg on T4 < 1 ng/ml determined by traditional assays?

Authors: Rosario, P. W.; Purisch, S.

Source: Clinical Endocrinology, Volume 68, Number 3, March 2008 , pp. 338-342(5)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Summary Objective 

To evaluate a highly sensitive thyroglobulin (Tg) assay [functional sensitivity (FS): 0·1 ng/ml] (Tg-ICMA) in low-risk patients with known Tg on T4 ≤ 1 ng/ml measured by a traditional assay (FS: 1 ng/ml) (Tg-IRMA). Methods 

Tg-ICMA was measured in serum samples stored at -70 °C. Samples were obtained 6 months or more after total thyroidectomy and remnant ablation with 131I, during L-T4 therapy (TSH < 0·4 mIU/l). All patients had well-differentiated and completely resected tumours, no ectopic uptake on post-therapy whole-body scans and were considered to be at low risk for recurrence. On the occasion of collection and retesting for this study, Tg-IRMA was ≤ 1 ng/ml in all samples and no antibody interference was observed. Results 

Tg-ICMA ≤ 0·1 ng/ml was observed in 130/178 (73%) patients and recurrence was diagnosed in only 1/130 (0·8%). Tg-IRMA measured after L-T4 withdrawal was > 1 ng/ml in 5/130 (3·8%) patients. Forty-eight (27%) patients had Tg-ICMA > 0·1 ng/ml (0·12-1·6 ng/ml) and recurrence was diagnosed in 5/48 (10·5%). Tg-IRMA measured after L-T4 withdrawal was > 1 ng/ml in 20/48 (41·6%) patients. A negative predictive value of 100% was achieved with Tg-ICMA on T4 ≤ 0·1 ng/ml combined with neck ultrasonography (US) or with stimulated Tg-IRMA ≤ 1 ng/ml. Conclusions 

Patients at low risk for recurrence with undetectable Tg on T4 measured by a highly sensitive assay (FS: 0·1 ng/ml) in the absence of antibody interference and with a negative sensitive neck US do not need to be submitted to Tg stimulation. Recurrence is rare in these cases and only a minority of patients convert to stimulated Tg > 1-2 ng/ml.

Document Type: Research article

DOI: 10.1111/j.1365-2265.2007.03043.x

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.16 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A